DiscGenics

DiscGenics

DiscGenics

Regenerative Cell Therapy for Chronic Back Pain.
Type
B2c
Founded
2007
Raised
$64M
Follow us
Alexa global traffic share
Latest funding
$50,000,000
Venture capital (Series C) - 2020
Ci:z Investment LLP Eagle Fund SP1 LLP Medical Incubator Japan (MIJ) +1
$14,000,000
Venture capital (Series B) - 2017
Mitsubishi UFJ Capital
Team Size
10+
Employees
$50,000,000 Venture capital (Series C)
FinSMEs

DiscGenics Raises $50M in Series C Funding